{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:16:57Z","timestamp":1788499017057,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbr.2026.116411","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:53:35Z","timestamp":1786805615000},"page":"116411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IFIT3 silencing improves the sensitivity of gliomas to temozolomide by inactivating the PI3K\/AKT signaling pathway"],"prefix":"10.1016","volume":"515","author":[{"given":"Yi","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2026.116411_bib1","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/s12885-024-12751-3","article-title":"Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression","volume":"24","author":"Wei","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbr.2026.116411_bib2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.5306\/wjco.v15.i8.982","article-title":"Current challenges in the treatment of gliomas: The molecular era","volume":"15","author":"Fern\u00e1ndez","year":"2024","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.bbr.2026.116411_bib3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.bbr.2026.116411_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.31083\/j.jin2205118","article-title":"Research progress in immunotherapy of gliomas","volume":"22","author":"Duan","year":"2023","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.bbr.2026.116411_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbr.2026.116411_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-031-23705-8_1","article-title":"Malignant glioma","volume":"1405","author":"Wang","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbr.2026.116411_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/0118744710300495240409074900","article-title":"Hypofractionated radiation therapy suppresses radioresistance in U87 human glioma cells by inhibiting Yap1 and Hsp90 proteins","volume":"17","author":"Khan","year":"2024","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.bbr.2026.116411_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbr.2026.116411_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126733","article-title":"Recurrent glioblastoma-molecular underpinnings and evolving treatment paradigms","volume":"25","author":"Chang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2026.116411_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27113507","article-title":"Temozolomide efficacy and metabolism: the implicit relevance of nanoscale delivery systems","volume":"27","author":"Petrenko","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbr.2026.116411_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s40478-025-02046-4","article-title":"Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights","volume":"13","author":"Li","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbr.2026.116411_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188616","article-title":"Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance","volume":"1876","author":"Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbr.2026.116411_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/0118744710258350230921065159","article-title":"Exposure to low-frequency radiation changes the expression of nestin, VEGF, BCRP and apoptosis markers during glioma treatment strategy: an in vitro study","volume":"17","author":"Amirinejad","year":"2024","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.bbr.2026.116411_bib14","doi-asserted-by":"crossref","first-page":"27582","DOI":"10.18632\/oncotarget.15175","article-title":"Long non-coding RNA in glioma: signaling pathways","volume":"8","author":"Shi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbr.2026.116411_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/genes16050600","article-title":"Signaling pathways in gliomas","volume":"16","author":"Stachyra","year":"2025","journal-title":"Genes. (Basel)"},{"key":"10.1016\/j.bbr.2026.116411_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbr.2026.116411_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/0115701646331003240821061517","article-title":"miR-124 in neuroblastoma: mechanistic insights, biomarker potential, and therapeutic prospects","volume":"21","author":"Kandegala Mahesh","year":"2024","journal-title":"Curr. Proteom."},{"key":"10.1016\/j.bbr.2026.116411_bib18","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.ncrna.2024.05.010","article-title":"The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways","volume":"9","author":"Mafi","year":"2024","journal-title":"Noncoding RNA Res."},{"key":"10.1016\/j.bbr.2026.116411_bib19","article-title":"IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbr.2026.116411_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10142-023-01282-y","article-title":"ETV7 promotes colorectal cancer progression through upregulation of IFIT3","volume":"24","author":"Chai","year":"2024","journal-title":"Funct. Integr. Genom."},{"key":"10.1016\/j.bbr.2026.116411_bib21","doi-asserted-by":"crossref","first-page":"7178","DOI":"10.7150\/thno.43093","article-title":"Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bbr.2026.116411_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12957-023-03274-5","article-title":"IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K\/AKT signaling pathway","volume":"22","author":"Liu","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbr.2026.116411_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9030324","article-title":"Current FDA-Approved Therapies for High-Grade Malignant Gliomas","volume":"9","author":"Fisher","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbr.2026.116411_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011208","article-title":"Overcoming chemotherapy resistance in low-grade gliomas: A computational approach","volume":"19","author":"Delobel","year":"2023","journal-title":"PLoS. Comput. Biol."},{"key":"10.1016\/j.bbr.2026.116411_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s13311-017-0519-x","article-title":"Glioma Subclassifications and Their Clinical Significance","volume":"14","author":"Chen","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbr.2026.116411_bib26","unstructured":"Fernandes C., Costa A., Os\u00f3rio L., et al. Current Standards of Care in Glioblastoma Therapy. In: De Vleeschouwer S, editor. Glioblastoma. Brisbane (AU): Codon Publications Copyright: The Authors.; 2017."},{"key":"10.1016\/j.bbr.2026.116411_bib27","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3390\/curroncol30020147","article-title":"Temozolomide Chronotherapy in Glioma: A Systematic Review","volume":"30","author":"Jia","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbr.2026.116411_bib28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41419-024-06938-6","article-title":"CHIP-mediated ubiquitin degradation of BCAT1 regulates glioma cell proliferation and temozolomide sensitivity","volume":"15","author":"Lu","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.bbr.2026.116411_bib29","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1111\/jcmm.15192","article-title":"MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1","volume":"24","author":"Chen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbr.2026.116411_bib30","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41417-021-00353-1","article-title":"Elevated GIGYF2 expression suppresses tumor migration and enhances sensitivity to temozolomide in malignant glioma","volume":"29","author":"Yang","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbr.2026.116411_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70213","article-title":"Paeonol Inhibits Cell Growth by Inducing Ferroptosis in Human Glioma Cells","volume":"14","author":"Li","year":"2026","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbr.2026.116411_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155635","article-title":"Curcumin-primed olfactory mucosa-derived mesenchymal stem cells mitigate cerebral ischemia\/reperfusion injury-induced neuronal PANoptosis by modulating microglial polarization","volume":"129","author":"Lan","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbr.2026.116411_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fmolb.2019.00148","article-title":"Emerging Functions of Human IFIT Proteins in Cancer","volume":"6","author":"Pidugu","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbr.2026.116411_bib34","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1158\/0008-5472.CAN-06-3820","article-title":"Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase","volume":"67","author":"Lavon","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbr.2026.116411_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14489","article-title":"A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response","volume":"30","author":"Duan","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbr.2026.116411_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.810572","article-title":"A novel inflammation-related lncRNAs prognostic signature identifies LINC00346 in promoting proliferation, migration, and immune infiltration of glioma","volume":"13","author":"Zeng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbr.2026.116411_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.37349\/etat.2023.00150","article-title":"An introductory review of post-resection chemotherapeutics for primary brain tumors","volume":"4","author":"McGovern","year":"2023","journal-title":"Explor. Target. Antitumor Ther."},{"key":"10.1016\/j.bbr.2026.116411_bib38","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1007\/s12094-025-03849-6","article-title":"Association of tumor treating fields (TTFields) therapy with overall survival in newly diagnosed glioblastoma","volume":"27","author":"Shah","year":"2025","journal-title":"Clin. Transl. Oncol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432826003876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432826003876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:28:42Z","timestamp":1788496122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432826003876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"alternative-id":["S0166432826003876"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2026.116411","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFIT3 silencing improves the sensitivity of gliomas to temozolomide by inactivating the PI3K\/AKT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2026.116411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116411"}}